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2Abstract
The increasing levels of obesity, and its associated co-morbidities, have prompted a 
reassessment of the techniques used for assessing body fat, including content, 
distribution and composition. Magnetic resonance spectroscopy (MRS) is amongst 
the many invaluable in vivo tools available today to evaluate the role of body fat in 
health and disease.  However, although MRS has become a powerful technique for 
assessing ectopic fat in vivo, it has had limited use in other areas of research 
associated with body fat. MRS has found some success as a fast method to 
determine whole body adiposity in rodent models of disease, as well as a non-
invasive method of obtaining an index of the overall composition of body fat in 
human subjects. Its more significant use has been in the understanding of bone 
marrow fat content, where important advances have been made, especially in 
longitudinal studies. In conclusion, in the area of body fat, MRS continues to be an 
adjunct technique to more precise and versatile MRI methods.
3Introduction
Obesity has become an important public health concern and significant resources 
are being channeled towards understanding the role of adipose tissue (body fat) and 
ectopic fat in the development of obesity-related co-morbidities. Accurate 
measurements of body fat content and distribution, in a fast and reproducible 
manner, have become increasingly important in both human and animal studies. 
There are a number of methods available to evaluate body fat content (and 
distribution). Conventional methodologies include indirect methods based on 
anthropometry (body mass index, BMI; waist and hip circumference), skin-fold 
measurements, bioelectrical appearance, underwater weighing and air 
plesmography, while more direct methods include imaging technology such as 
computer tomography/dual-energy-X-ray absorptiometry (CT/DXA) and magnetic 
resonance imaging (MRI)1. While MRI has become the gold standard for measuring 
body fat content and distribution2, the large number of images generated, particularly 
from whole body scans, together with the lack of fast, affordable and automated 
methods of analysis, has driven the search for faster more efficient methods of data 
acquisition and analysis. 
Magnetic resonance spectroscopy (MRS) has been proposed as a simple alternative 
to assess body fat content, distribution and composition in human subjects and 
animal models. In this chapter we will review the pros and cons of this approach and 
4give examples of where this technique can provide valuable information in basic and 
clinical research.
MRS has been applied in a number of ways to assess body fat:
1. To assess the composition of adipose tissue (AT)
2. As a measure of whole body adiposity 
3. To measure ectopic fat content in lean tissue (muscle, liver, heart, pancreas 
and kidneys)
4. For assessing bone marrow adipose tissue (MAT) content
5. To discriminate between white (WAT) and brown adipose tissue (BAT)
1.0Composition of Adipose Tissue
1.1In vivo 13C MRS of adipose tissue
It is well established that the distribution of AT is associated with incidence of 
coronary heart disease (CHD), but there is also considerable interest in the 
association between AT composition and disease. Previous studies have shown 
that low levels of unsaturation (long-chain polyunsaturated fatty acids n-3 and n-
6) in the AT are associated with increased risk of CHD3. Moreover, there is a 
progressive inverse relationship between linoleic acid AT reserves, platelet 
membrane eicosapentaenoic acid (EPA) and risk of angina pectoris, independent 
of traditional CHD risk factors4. 
5Examination of the fatty acid (FA) composition of AT has traditionally required 
samples obtained by biopsy or at post-mortem for in vitro analysis by gas liquid 
chromatography (GLC) following chemical extraction. However, routine 
assessment of lipid composition by repeated biopsy invokes both ethical and 
practical difficulties, limiting its use in serial studies, as for example examining 
longitudinal dietary effects on AT composition. Similarly, exploration of deeper AT 
depots, such as intra-abdominal AT (“visceral fat”), are not feasible using this 
invasive methodology. 
Non-invasively, the main in vivo MR technique to assess AT composition has 
been 13C MRS. The low natural abundance of 13C (only 1.1% compared with the 
more abundant 12C isotope), has restricted its application mainly to the more 
expensive 13C-isotope enrichment studies (see emrstm1841/1468). However, 
even at the level of natural abundance there is sufficient 13C within adipose 
tissue, to make non-enriched 13C MRS possible. A typical 1H-coupled 13C-
spectrum from the subcutaneous AT of the thigh of a healthy volunteer is shown 
in Figure 1.  Over 25 signals can be clearly discerned, all arising from the carbon 
atoms within the acyl-chain of the triglyceride molecules stored within adipocytes, 
the main cellular component of AT. Signal from other lipids, including cholesterol 
and phospholipids cannot be normally detected by in vivo 13C of AT, as these 
cellular components are normally tightly packed within membrane structures 
and/or bound to macromolecules, making them “invisible” to standard MRS 
techniques (Table 1).
<Figure 1 near here>
6<Table 1 near here>
To date the main application of in vivo 13C-MRS has been to examine the long-
term effects of diet on the composition of AT in rodents5,6 and humans7-10.  As 
early as 1983, Canioni et al showed that modulation of essential fatty acids in the 
diet of rats altered the 13C-MR spectrum of adipose tissue5. Chronic restriction 
resulted in a decrease of resonances arising from polyunsaturated fatty acids, 
while supplementation resulted in a significant increase. From this they 
postulated that the polyunsaturated peak at 128.5 ppm in the decoupled 
spectrum (corresponding to peaks 3 and 5 in the coupled version in Figure 1) 
could be used as a non-invasive biomarker of dietary polyunsaturated fat intake5. 
Similarly Fan et al showed that the spectra of adipose tissue from rats fed either 
olive, safflower or menhaden oil for 17 days, was remarkable similar to the 13C 
MR spectra from each of the oils6. Furthermore, 13C MRS could be used to 
monitor changes in the adipose tissue profiles as the rats were switched to 
between the different diets6.
Studies in humans have demonstrated similar results, with 13C MRS shown to be 
a long term biomarker of habitual dietary intake. Beckmann et al found that the 
level of unsaturation measured from the 13C MR spectra of adipose tissue from 
volunteers following 6 months adherence to either a fat-reduced or high-fat diet 
agreed with that assessed from their subjects’ dietary history8. Similarly Thomas 
et al reported clear differences between the adipose tissue composition of 
vegans, vegetarians and omnivores, which was strongly linked to the fatty acid 
7composition of their habitual diet9. Interestingly, the high levels of 
polyunsaturated fatty acids observed in the adipose tissue of vegan subjects 
were negatively associated with both total and low density lipoproteins (LDL)-
cholesterol, suggesting that 13C MRS could indeed be used as a non-invasive 
measure of ‘metabolic health’9. Similarly, Hwang et al reported significantly 
elevated levels of monounsaturated and polyunsaturated fatty acids from the 13C 
MR spectra of the adipose tissue of subjects following diets supplemented with 
either fish oil or Lorenzo's oil (high in monounsaturated fatty acids)10.
There have also been several applications of 13C-MRS to diseases such as cystic 
fibrosis, where reduced levels of adipose polyunsaturated fatty acids have been 
reported7,11. Interestingly despite GLC of adipose tissue samples revealing 
significant reductions in omega-3 FAs between malnourished patients prior to 
liver transplantation, no significant differences were found by 13C MRS of adipose 
tissue12. However, at the follow-up scan, 8 weeks after successful 
transplantation, an increase in the overall level of saturated fatty acids was 
observed. Whether this was a reflection of the dietary composition during this 
time, or an indication of unsaturated fatty acids tending to be preferentially 
utilized for metabolic or structural functions during this period of recovery is 
unclear12.
13C MRS has been further applied to the study of neonatal adipose tissue 
composition13. Thomas et al showed that the fatty acids composition of infants at 
birth was more saturated compared with their mothers. During the first 6 weeks of 
8life, there was an increase in the level of unsaturated fatty acids, though this still 
did not reach the levels measured in adults13. 
In conclusion, 13C MRS is a robust and reproducible method for the assessment 
of AT composition, and several studies have shown generally good agreement  
between in vivo 13C MRS and GLC analysis of AT biopsy samples.7,14 
Nevertheless 13C MRS has not really been applied outside a small number of 
research centers. One of the main obstacles is the limited availability of 13C MRS 
capability in most clinical and research centers. Another important issue with this 
technique is that although it can be used to assess overall levels of saturated, 
mono- and polyunsaturated FAs, it cannot distinguish between individual FAs, an 
important consideration given the well-established metabolic and functional 
differences of different FAs. Furthermore, most 13C MRS studies to date have 
employed surface coils without localization, which generally only allows for the 
study of subcutaneous AT.
1.21H MRS of adipose tissue
More recently 1H-MRS has been applied to measure the composition of AT and has 
been shown to agree well with measurements made using GLC, particularly at 
longer echo times (TE = 135ms)15. 1H MRS has the advantage of utilizing routine 
localization sequences such as PRESS (point resolved spectroscopy) or STEAM 
(stimulated echo acquisition mode), allowing measurements of the composition of 
both subcutaneous and internal AT depots, such as visceral AT16, the latter being 
metabolically more interesting than the former adipose tissue stores. It has also 
enabled the study of regional compositional differences within the subcutaneous AT 
9depot, allowing comparisons between the composition of deep vs superficial 
subcutaneous AT to be made17. A typical 1H-spectrum from adipose tissue with 
associated peak assignments is shown in Figure 2.
<Figure 2 near here>
Whilst there is limited research in this area, there have been some interesting 
observations reported using this technique. For example Machann et al reported a 
significant variation in composition of visceral AT between subjects16. They also 
found a significant correlation between the composition and quantity of visceral AT 
present in different subjects, with those found to have the least volume of visceral fat 
having the highest unsaturated index.  Similarly Lundbom et al found deeper layers 
of subcutaneous AT to be more saturated than more superficial layers, a change 
attributed to reduced mono-unsaturated fatty acids, since no differences in 
polyunsaturated fatty acids were observed at different depths17.
However, like with 13C-MRS, assessment of AT composition by 1H MRS does not 
provide full detail of the different type of fatty acid within the triglycerides, and only 
enables differentiation between major classes of FA: saturated vs unsaturated, 
polyunsaturated vs monounsaturated etc. Thus, for identification of individual FA it is 
still necessary to collect biopsy samples for analysis by GLC.
Localized 1H MRS has also been used in the study of the nature of cellulite within 
subcutaneous AT18. Deep indentation in the dermis (“cellulite”) observed in some 
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subjects, especially women, is frequently reported and is the focus of many 
resources from the cosmetic industry. Cellulite is popularly believed to arise from 
“water retention” within this tissue. However, the results from this  1H MRS study18 do 
not confirm this, but rather suggest that water retention may be taking place within 
the connective tissue septae rather than the AT.
2.0 Whole Body Adiposity
Whilst most MR studies of AT have focused on using imaging-based techniques, a 
small number, particularly in rodent studies, have opted for the use of 1H MRS. 
Generally, whole body measurement of fat content using 1H MRS can only be made 
if the subject matter being scanned fits in its entirety within the transmit/receive 
(Tx/Rx) coils. Hence this method has mainly focused on the study of small animals, 
including rodents and poultry19-25, with some minor applications in human subjects26-
29. One of the principal motivations for using 1H MRS, compared with MRI, appears 
to be the speed of acquisition and the simplicity of its analysis. Indeed, a whole body 
1H MRS can be obtained in <1 second, leading generally to a spectrum consisting of 
just 2 peaks: water at 4.7 ppm and fat at 1.3 ppm, and the resulting analysis is 
simply their ratio, Figure 3. Compared to a whole body MRI scan, which requires 
significant analysis time (>30 mins), 1H MRS of large data sets, with its rapid 
acquisition and analysis, becomes extremely attractive. 
<Figure 3 near here>
To date there have been several validation studies of this technique on mice19 and 
rats21, where body fat content measured using whole body 1H MRS has been 
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compared with lipid extraction of the carcass. Good correlations and agreement were 
reported between MRS and extracts. 
Yet, despite the excellent agreement between the 1H MRS and carcass analysis, 
adiposity measurements by this technique are not always directly comparable to 
those reported by other methods, particularly MRI and CT.  1H MRS measures total 
body fat content (principally triglycerides within the AT, although there are 
contributions from fat deposited in tissues such as the liver, muscle and bone 
marrow as well as fatty intestinal contents), while MRI is a measure of total AT 
volume, which is comprised of more than just triglycerides within the adipocytes, and 
includes contribution from water within this tissue. Water content within AT can reach 
as much as 30% of the total volume, especially in neonates and some disease state. 
Thus, caution must be taken in interpreting the fat/water ratio obtained by 1H-MRS, 
as changes in the fat content detected by this technique may be a consequence of 
real variations in fat content – or simply reflect changes due to increases in tissue 
hydration or edema. Interestingly, the very difference between MRS and MRI outputs 
could in theory be utilized to assess changes in AT hydration, although interpretation 
of the results may not be straight forward. 
In human subjects, the application of 1H MRS has been partly hindered by the fact 
that without localization both magnet and embedded Tx/Rx coils are too short to 
accommodate a whole subject, except neonates and young children. Furthermore, it 
is difficult to determine the different anatomical contributions to the overall spectrum, 
while field inhomogeneity beyond the central area of the magnet can lead to 
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broadening of signals and distortion of the relative fat/water ratio26,27. In order to 
overcome some of these difficulties Weis et al used a high-speed spectroscopic 
imaging technique to map body fat from head-to-toe28. Spectra were obtained from 
several thick-slices corresponding to contiguous sections of the body, give excellent 
quantitation of total body fat and an additional insight into gender differences in 
regional fat distribution (see Figure 4). 
<Figure 4 near here>
However, if the 1H-MRS measurements of total body fat are contrasted with those 
obtained by whole body MRI techniques, it can be clearly seen that in humans there 
is little value in its application. MRI techniques such as T1-weighted or water-fat 
imaging can deliver whole body scanning in a matter of minutes and with recent 
advances in automated image analysis, assessment of body fat content and 
distribution can be achieved in most clinical scanner2. Typical whole-body coronal 
T1-weighted images from a series of volunteers are shown in Figure 5. Individual 
images were obtained < 6 minutes and allow for content and distribution of body fat 
and muscle to be readily obtained with high accuracy and reproducibility. Similar 
results could not be readily achieved with  1H MRS and thus total body fat 
measurements using in vivo spectroscopy will continue to be of limited used as it 
fails to provide sufficient information regarding body fat distribution, especially from 
visceral fat. 
<Figure 5 near here>
3.0 Ectopic Fat 
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In no other area of research has 1H MRS been used as extensively as in the study of 
ectopic fat, including muscle, liver, heart and pancreas. Indeed, 1H MRS of liver fat 
has become the gold standard in clinical research, especially in longitudinal studies 
where serial biopsies are impractical and unethical. In other areas of clinical 
research this is the sole technique available to determine fat content of certain 
organs, including the pancreas and heart, each of which produces an invaluable 
stream of data that continues to inform both scientific and clinical research.  We will 
however not cover this topic in this review and point the reader to other chapters in 
this volume (emrstm1470, 1462, 1436, 1453) for a full description of the use of MRS 
in the study of ectopic fat. It should be noted however, that water-fat imaging 
techniques are being developed and implemented to assess ectopic fat deposits 
such as in liver and pancreas and are likely to be of considerable use in clinical 
scanners that do not have MRS capabilities 30-32. 
4.0 Bone Marrow
There is renewed interest in understanding the relationship between marrow AT 
(MAT) and bone function, including osteoporosis33. Osteoporosis is a chronic 
disorder with particularly high prevalence amongst the older population, leading to 
increased disability and mortality. Contrary to common perception, osteoporosis 
appears to be linked to obesity, with some researchers suggesting a potential causal 
effect. Furthermore, type-2 diabetes, which is closely associated to obesity, is also 
linked to increased risk of bone fracture despite normal or above average bone 
density. 
14
Bone marrow consists mainly of hematopoietic tissue ("red marrow") and fat cells 
("yellow marrow" or MAT). MAT was thought for a long time to be metabolically inert; 
however, recent studies have begun to reassess the role of fat cell in bone, with 1H 
MRS playing an important role in this process34-43. 
A typical 1H MRS spectrum from bone marrow from a healthy volunteer (A) and a 
subject with pathology (B) can be seen in Figure 6. It consists primarily of peaks 
arising from water and lipids. The lipid signal itself consisting of resonances from –
CH3, -(CH2)n- and HC=CH protons from triglycerides within adipocytes. From these 
signals it is possible to obtain a relative % fat fraction (%FF) of bone marrow as well 
as the relative level of unsaturation. Despite the rather limited number of signals 
arising from a typical 1H MR spectrum of bone marrow, MRS has greatly improved 
understanding of the relationship between MAT and bone quality and function. 
<Figure 6 near here>
Schellinger et al, published normative values of MAT in lumbar vertebral bone, 
showing that there is an age-dependent increase and that levels of MAT are gender-
dependent, with higher concentration being observed in males (Figure 7)35. They 
then went on to present data suggesting that %FF may have predictive value in 
determining bone weakness, with elevated MAT levels being positively associated 
with increased long term vertebral weaknesses36. Indeed, MAT content is inversely 
correlated with bone mineral density (BMD) and is a strong predictor of bone integrity 
and function38,40.  However, despite the association between MAT and BMD, 1H-
15
MRS of bone marrow is not predictive of the development or duration of lower-back 
pain37. 
<Figure 7 near here>
Recently, positive associations have been reported between MAT and visceral fat, 
ectopic fat and serum lipid, suggesting that similar factors may influence lipid 
deposition in all of these compartments41. However, no such association was found 
between overall adiposity and MAT42. Interestingly MAT is increased in patients with 
anorexia nervosa, characterized by extreme weight loss43, and MAT can recover to 
normal levels once weight is normalised33. There have also been studies of changes 
in MAT after gastric bypass surgery: following the large reductions in overall 
adiposity MAT also reduced, but interestingly only in non-diabetic subjects44. It 
seems that 1H MRS is particularly well suited to the non-invasive study of this unique 
adipose tissue depot.
5.0 Brown Adipose Tissue
The discovery of brown adipose tissue (BAT) in adult human subjects by PET/CT 
has prompted a frenetic search for potential none-invasive methodologies that do not 
require the use of a radioactive tracer for its quantitation. Several MR alternatives 
have been put forward, including 1H-MRS.
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BAT is a pivotal organ for the regulation of body thermogenesis in rodents and 
neonates. More recently, through the use of PET/CT, distinctive BAT depots have 
been identified in human adults. The presence of BAT has been shown to be 
inversely correlated to BMI, suggesting that it may play an important role in obesity.  
So far most of the in vivo work on BAT quantitation and function has been carried out 
using PET/CT, which has greatly limited human research.  Several groups have 
attempted to utilize 1H-MRS to differentiate between white adipose tissue (WAT) and 
BAT in vivo based on their differences in cellular composition45-47. WAT consists 
mainly of adipocytes, with unilocular lipid droplets and limited intracellular water, 
while in BAT the adipocytes are smaller, multilocular and rich in metabolically active 
mitochondria and intracellular water. 
However, despite these significant cellular differences, to date most of the research 
using 1H MRS has only managed to show that WAT and BAT differ in level and 
composition of lipids and reduced water T1 relaxation rates45-47. Using quantitative 
1H-MRS, BAT has been shown to have lower levels of fatty acid unsaturation and 
polyunsaturation, decreasing even further during BAT stimulation through cold 
exposure or norepinephrine administration. Furthermore, the unsaturation index of 
BAT has been shown to be inversely related to the age of the volunteer, confirming 
previous in vitro studies.  Similarly, Peng et al showed that WAT had a higher FF 
than BAT, but that difference depended on the genetic strain of the mice48. Ob/ob 
and Fsp27 gene knock-out mice, genetic models of severe obesity, showed similar 
differences in FF between WAT and BAT as seen in wild-type, while no differences 
were observed in SKO mice, suggesting  differences regulatory effects of the ob, 
seipin and Fsp27 genes on the development of WAT and BAT48.
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Overall, the impact of in vivo 1H-MRS on the study of BAT, both from a quantitative 
and functional point of view, has been rather limited. Much more promising are the 
results arising from the use of MRI to differentiate and quantitate BAT from WAT30,49. 
Both, relaxometry-based (T1, T2) and chemical shift-based approaches appear quite 
promising, yet further validation is required before MRI and MRS methods can 
replace PET/CT for the study of BAT in human subjects.
In conclusion, MRS techniques have contributed greatly to our understanding of 
adipose tissue function in humans and animal models, especially in the area of fat 
composition and ectopic fat deposition. However, compared to MRI techniques, it 
has had a rather limited impact on our understanding of the factors that determine 
body fat content and distribution. As such, MRS is likely to continue to be an adjunct 
to more accurate and sophisticated imaging techniques.
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Table 1. Assignment and Frequencies of Resonances in a Coupled 13C NMR 
Spectrum of in Vivo Human Adipose Tissue
Peak Splitting Assignment Chemical Shift (ppm)
1 singlet -CH2-*CO 172.1
2 + 4 doublet -*CH=CH-CH2-
CH=*CH-
134.9 and 125.4a (130.0)b
3 + 5 doublet -CH=*CH-CH2-
*CH=CH-
133.4 and 124.2 (128.4)
6 + 8 doublet C2 glycerol 69.2 and 68.1 (69.5)
7, 9, 10 triplet C1 + C3 glycerol 62.9, 61.7 and 60.6 (62.2)
11, 15 triplet -CH2-*CH2-CO 42.9, 34.8 and x (34.2)
12, 16 triplet -*CH2-CH2-CH3 41.0, 33.4 and x (32.3)
13, 17, 20 triplet -(*CH2)n- 38.7, 30.8 and 22.9 (30.1)
14, 18, 21 triplet -CH=CH-*CH2-CH2- 36.2, 28.3, 20.6 (27.6)
triplet -CH=CH-*CH2-
CH=CH-
x, x, x (25.5)
23 triplet -*CH2-CH2-CO x, x and 16.2 (25.2)
triplet -CH2-*CH2-CH3 x, x, x (23.1)
24
19,22,24,25 quartet CH2-*CH3 3.36, 11.2, 18.9, 26.7 
(14.2)
Notes: aValues refer to resonance position in the coupled 13C NMR spectrum;  
bSingle values in parentheses refer to resonance position in the decoupled 13C NMR 




Figure 1. Non-localized, fully relaxed, 1H-coupled 13C-spectrum of adipose tissue 
from a healthy adult volunteer. The spectrum was acquired from the right thigh of the 
volunteer on a 1.T system (Phillips; Netherland), using a 10 cm surface coil, in 
approximately 4 minutes with a TR of 30s. Details of peak assignment are shown in 
Table 1. 
Figure 2: (a) Chemical groups of a triglyceride molecule with chemical shift, 
assignment and name of the corresponding resonance. (b) In vivo spectrum (right) of 
visceral adipose tissue from the MRI voxel location (left) with the peaks labeled 
(adapted from Ref. 14).
Figure 3. Typical 1H MR spectra from mice with varying levels of adiposity. The fat 
peak (right side) increases relative to the water with increasing adiposity.
Figure 4: 1H MR spectra from different parts of the body of a female (A) (BMI = 23.7 
kg/m2) and male (B) (BMI = 21 kg/m2) volunteer, with accompanying silhouette to 
demonstrate slab position (adapted from 26).
Figure 5. Typical MR coronal images obtained from a group of healthy female 
volunteers. Images were acquired on a 1.5T system using a T1-weighted imaging 
26
sequence using a series of scanning blocks (n=9-12) to for a head-to-toe coverage. 
The volunteers are ordered according to their self-reported UK clothes sizes (UK 
size 6 – UK size 20), with corresponding BMI from left to right of 20.4 kg/m2, 18.7 
kg/m2, 21.9 kg/m2, 23.0 kg/m2, 25.7 kg/m2, 27.3 kg/m2, 34.9 kg/m2, and 32.2 kg/m2.
Figure 6. Comparison of (A) normal bone in a healthy teenage girl and (B) a patient 
with vertical disc herniations at the inferior endplates of L2 and L3. The 1H MRS 
shows the lipid peak (right) to be much higher than the water peak (left). In (A) the 
percentage fat fraction (%FF) was estimated at 16; in (B) the %FF was significantly 
higher, 64. (Adapted from Ref. 36).
Figure 7. MAT fraction of both normal and abnormal bone marrow increases with 
age. Abnormal bone has a higher %FF in all age groups (Adapted from Ref. 36).
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